A £10million Centre of Excellence in Precision Medicine was launched today by Invest Northern Ireland and Queen’s University Belfast.
“This new Precision Medicine Centre will provide access to R&D facilities for both local and international companies. It has the potential to develop ground breaking treatments for cancer patients and will further enhance the personalised medicine and oncology research sector in Northern Ireland. While initially research will focus on cancer, this could extend into other areas of precision medicine in the future.
“Northern Ireland has a strong and internationally recognised Life & Health Sciences sector, which boasts globally renowned leaders including Almac and Randox. The Centre will contribute to the continued international recognition of Northern Ireland based research in this field.
“The Centre will also create 17 new high quality roles which will generate over £800,000 in annual salaries for the Northern Ireland economy.”
“Queen’s University Belfast is at the forefront of Molecular Pathology, biomarker validation and test adoption in the UK. This Centre of Excellence brings a unique dimension to the bridging of academia and industry, making the fabric of our biotechnology sector in NI and the UK as a whole significantly stronger.”
Queen's University Belfast is committed to Equality, Diversity and Inclusion.
For more information please read our Equality and Diversity Policy.
Queen's University Belfast is registered with the Charity Commission for Northern Ireland NIC101788
VAT registration number: GB 254 7995 11